1.70
0.06 (3.79%)
| Previous Close | 1.64 |
| Open | 1.65 |
| Volume | 25,976 |
| Avg. Volume (3M) | 70,298 |
| Market Cap | 17,290,104 |
| Price / Earnings (Forward) | 2.35 |
| Price / Sales | 0.010 |
| Price / Book | 0.140 |
| 52 Weeks Range | |
| Earnings Date | 22 Sep 2025 - 26 Sep 2025 |
| Profit Margin | 1.67% |
| Operating Margin (TTM) | 7.86% |
| Diluted EPS (TTM) | 4.25 |
| Quarterly Revenue Growth (YOY) | -28.00% |
| Quarterly Earnings Growth (YOY) | -32.90% |
| Total Debt/Equity (MRQ) | 17.01% |
| Current Ratio (MRQ) | 2.42 |
| Operating Cash Flow (TTM) | -7.72 M |
| Levered Free Cash Flow (TTM) | -8.58 M |
| Return on Assets (TTM) | 2.16% |
| Return on Equity (TTM) | 0.91% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Specialty Chemicals (US) | Bullish | Bearish |
| Specialty Chemicals (Global) | Bullish | Mixed | |
| Stock | Bon Natural Life Limited | - | - |
AIStockmoo Score
| Analyst Consensus | 2.0 |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | -1.0 |
| Technical Oscillators | -0.5 |
| Average | -0.38 |
|
Bon Natural Life Ltd is engaged in the manufacturing of personal care ingredients, such as plants extracted fragrance compounds to perfume and fragrance manufacturers, natural health supplements such as powder drinks and bioactive food ingredient products mostly used as food additives and nutritional supplements. The company has its geographic presence in PRC and in Overseas. The company derives maximum revenue from perfumes and fragrance products. |
|
| Sector | Basic Materials |
| Industry | Specialty Chemicals |
| Investment Style | Small Value |
| % Held by Insiders | 48.44% |
| % Held by Institutions | 1.59% |
No data within this time range.
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 10 Dec 2025 | Announcement | BON Unveils Kombucha-Inspired Product, Inks $12 Million Strategic Sales Agreement with Qingshengyuan |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |